SCHEMBL7984716

SCHEMBL7984716

Cc1ccc(Cn2cnc3nc(-c4ccccc4)[nH]c(=O)c32)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
KMT2A Q03164 2/20 0.52
TNKS O95271 1/20 0.45
PARP1 P09874 1/20 0.45
TNKS2 Q9H2K2 1/20 0.45
LMNA P02545 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
HTT P42858 1/20 0.43
BRD4 O60885 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
POLB P06746 1/20 0.42
PDE5A O76074 1/20 0.41
PARN O95453 1/20 0.40
CNOT7 Q9UIV1 1/20 0.40
MEN1 O00255 1/20 0.40
PNP P00491 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975265 0.92 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7985058 0.90 HPGD (0.44) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7985823 0.90 HPGD (0.44) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA
SCHEMBL7991402 0.89 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7985164 0.89 KMT2A (0.46) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7985321 0.88 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7986518 0.88 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7984419 0.88 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA
SCHEMBL7991594 0.88 HPGD (0.44) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA
SCHEMBL7984766 0.88 HPGD (0.44) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed